Department of Medicine, University of Illinois at Chicago, Chicago, Illinois.
Oxford University Medical School, Oxford, United Kingdom.
Ann Am Thorac Soc. 2019 Sep;16(9):1143-1150. doi: 10.1513/AnnalsATS.201809-607OC.
Adults may exhibit characteristics of both asthma and chronic obstructive pulmonary disease (COPD), a situation recently described as asthma-COPD overlap (ACO). There is a paucity of information about ACO in primary care. To estimate the prevalence and describe characteristics of individuals with ACO in primary care practices among patients currently diagnosed with asthma, COPD, or both; and to compare the prevalence and characteristics of ACO among the three source populations. The Respiratory Effectiveness Group conducted a cross-sectional study of individuals ≥40 years old and with ≥2 outpatient primary care visits over a 2-year period in the UK Optimum Patient Care Research Database. Patients were classified into one of three source populations based on diagnostic codes: ) COPD only, ) both asthma and COPD, or ) asthma only. ACO was defined as the presence of all of the following ) age ≥40 years, ) current or former smoking, 3) post-bronchodilator airflow limitation (forced expiratory volume in 1 second/forced vital capacity <0.7), and ) ≥12% and ≥200 ml reversibility in post-bronchodilator forced expiratory volume in 1 second. Among 2,165 individuals (1,015 COPD only, 395 with both asthma and COPD, and 755 asthma only), the overall prevalence of ACO was 20% (95% confidence interval, 18-23%). Patients with ACO had a mean age of 70 years (standard deviation, 11 yr), 60% were men, 73% were former smokers (the rest were current smokers), and 66% were overweight or obese. Comorbid conditions were common in patients with ACO, including diabetes (53%), cardiovascular disease (36%), hypertension (30%), eczema (23%), and rhinitis (21%). The prevalence of ACO was higher in patients with a diagnosis of both asthma and COPD (32%) compared with a diagnosis of COPD only (20%; < 0.001) or asthma only (14%; < 0.001). Demographic and clinical characteristics of ACO varied across these three source populations. One in five individuals with a diagnosis of COPD, asthma, or both asthma and COPD in primary care settings have ACO based on the Respiratory Effectiveness Group ACO Working group criteria. The prevalence and characteristics of patients with ACO varies across the three source populations.
成年人可能同时表现出哮喘和慢性阻塞性肺疾病(COPD)的特征,这种情况最近被描述为哮喘-COPD 重叠(ACO)。初级保健中关于 ACO 的信息很少。本研究旨在评估目前诊断为哮喘、COPD 或两者并存的患者在初级保健实践中 ACO 的患病率,并描述其特征;并比较这三种来源人群中 ACO 的患病率和特征。呼吸有效性研究组(Respiratory Effectiveness Group)在英国 Optimum Patient Care Research Database 中进行了一项横断面研究,纳入了 2 年内≥40 岁且有≥2 次门诊初级保健就诊的患者。患者根据诊断代码分为以下三种来源人群之一:) COPD 组、) 哮喘和 COPD 共存组或 ) 哮喘组。ACO 的定义为以下所有特征的存在:) 年龄≥40 岁、) 当前或既往吸烟、3) 支气管扩张剂后气流受限(第 1 秒用力呼气量/用力肺活量<0.7)、和 ) 支气管扩张剂后第 1 秒用力呼气量的可逆性≥12%和≥200ml。在 2165 名患者(COPD 组 1015 名,哮喘和 COPD 共存组 395 名,哮喘组 755 名)中,ACO 的总体患病率为 20%(95%置信区间,18-23%)。ACO 患者的平均年龄为 70 岁(标准差为 11 岁),60%为男性,73%为既往吸烟者(其余为当前吸烟者),66%为超重或肥胖。ACO 患者合并症常见,包括糖尿病(53%)、心血管疾病(36%)、高血压(30%)、湿疹(23%)和鼻炎(21%)。哮喘和 COPD 共存患者的 ACO 患病率(32%)高于 COPD 组(20%;<0.001)或哮喘组(14%;<0.001)。这些三个来源人群的 ACO 患者的人口统计学和临床特征不同。在初级保健环境中,根据呼吸有效性研究组 ACO 工作组标准,诊断为 COPD、哮喘或哮喘和 COPD 共存的患者中,有五分之一患有 ACO。ACO 患者的患病率和特征在这三个来源人群中有所不同。